Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?
Check out this crisp VA by Dr Akshaya Jayachandran.
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
This week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low?
Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?
Check out this crisp VA by Dr Akshaya Jayachandran.
Can we train to deal with the pain? HOPE trial shows us that non-pharmacological intervention can be an option. Visual abstract by Cristina Popa
Check out the dreamy Visual Abstract by Cristina Popa
Any sleep potion for insomnia in patients on hemodialysis?
Effects of Technology Assisted Stepped Collaborative Care Intervention to Improve Symptoms in Patients Undergoing Hemodialysis (Jhamb, JAMA Internal Medicine 2023)
Exercise during Hemodialysis in Patients with Chronic Kidney Failure (Anding-Rost, NEJM Evidence 2023)
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients (JAMA 2024)
Huge trial on our core work, catch-up here
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) July 31, 2023
✳️10 tweets #NephJC catch-up ✳️
🌟Let’s recap the CONVINCE trial which pitted HDF against HD
🌟Do we now have CONVINCE-ing evidence for the superiority of convection added to diffusion? pic.twitter.com/92gW0zKv76
The last NephJC of the year brought us a cool discussion on if cooling dialysate could help mitigate the effects of intradialytic hypotension. Get caught up with the chat in the latest edition of #TenTweetNephJC.
Last #TenTweetNephJC thread of 2022
— Nephrology Journal Club (@NephJC) December 28, 2022
Intradialytic hypotension (IDH) is deeply unpleasant but very common. We hope cooling dialysate to cause vasoconstriction prevents IDH, helping prevent myocardial stunning.
So does cooling dialysate improve cardiovascular outcomes? pic.twitter.com/mmNoIxlDxk
Dr. Aarthi designed this nice visual abstract for this week’s chat.